Zoledronic Acid Treatment After Acute Spinal Cord Injury: Results  of a Randomized, Placebo-Controlled Pilot Trial

Conclusions Zoledronic acid is effective at mitigating bone loss after SCI. Duration of efficacy and activity at different skeletal sites may differ from that observed in able-bodied individuals and needs further study.
Source: PMandR - Category: Rehabilitation Source Type: research